Yilong Wu

Stephen V Liu: Yilong Wu shows the Potential of PD1/VEGF Bispecifics in driver positive NSCLC at Rome Lung 25

Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:

“Dr. Yilong Wu Thomas Wu shows the potential of PD1/VEGF bispecifics in driver positive NSCLC at RomeLung25.
HARMONi-A showed the PFS benefit of ivonescimab in EGFR NSCLC. BNT-327 showed much greater benefit with higher PDL1 expression.
Will this impact survival?”

Stephen V Liu: Yilong Wu shows the Potential of PD1/VEGF Bispecifics in driver positive NSCLC at Rome Lung 25

More posts featuring Stephen V Liu.

BNT-327 cancer EGFR fight against cancer Georgetown University Global fight against cancer HARMONi-A ivonescimab NSCLC OncoDaily Oncology PD1 PDL1 RomeLung25 Stephen V Liu VEGF Yilong Wu